A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma.

Blanke CD, Haller DG, Benson AB, Rothenberg ML, Berlin J, Mori M, Hsieh YC, Miller LL
Ann Oncol. 2001 12 (11): 1575-80

PMID: 11822757 · DOI:10.1023/a:1013129315036

MeSH Terms (19)

Adenocarcinoma Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Camptothecin Esophagogastric Junction Female Fluorouracil Humans Irinotecan Leucovorin Male Middle Aged Neoplasm Recurrence, Local Neutropenia Stomach Neoplasms Survival Rate Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: